Skip to main content
SpringerLink
Log in

Evaluation of the efficiency of an assay procedure for gangliosides in human serum

  • Papers Dedicated To Dr Sen-Itiroh Hakomori
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

An efficiency assessment of a ganglioside assay procedure was carried out on human serum gangliosides from healthy subjects of different sex and age. The analysis of the gangliosides, extracted with chloroform/methanol and purified by lipid partitioning, ion exchange column chromatographic separation and desalting procedures as described by Sennet al. (1989)Eur J Biochem 181: 657–62, was performed by HPTLC followed by densitometric quantification. The yield of the procedure, expressed as radioactivity recovery, was determined by adding GM3 ganglioside, tritium labelled at the sialic acid acetyl group and at the C3 position of sphingosine, to the lyophilized serum or by associating it with the serum lipoproteins. In spite of the fact that the extraction and purification procedures were performed exactly as described we found the radioactivity recovery to be variable (25–50%) and much lower than that proposed. Much of the radioactivity was found in the organic phase after lipid partitioning, whilst all the ganglioside purification steps led to some further loss. After the introduction of some modifications to the procedure the recovery improved, reaching 67–79%.

The analyses on 33 samples of 5 ml showed a human serum ganglioside content of about 10 nmol ml−1 (as corrected for the recovery), and confirmed that GM3 ganglioside is the main component of the total serum ganglioside mixture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Senn H-J, Orth M, Fitzke E, Wieland H, Gerok W (1989)Eur J Biochem 181: 657–62.

    Google Scholar 

  2. Wiegandt H (1985)New Compr Biochem 10: 199–266.

    Google Scholar 

  3. Hakomori S-I (1981)Ann Rev Biochem 50: 733–64.

    Google Scholar 

  4. Dawson G, Kruski AW, Scanu AM (1976)J Lipid Res 17: 125–31.

    Google Scholar 

  5. Clarke JTR (1981)Canad J Biochem 59: 412–17.

    Google Scholar 

  6. Chatterjee S, Kwiterovich PO (1984)Canad J Biochem Cell Biol 62: 385–97.

    Google Scholar 

  7. Valentino LA, Ladisch S (1992)Cancer Res 52, 810–14.

    Google Scholar 

  8. Shaposhnikova GI, Prokazova NV, Buznikov GA, Zvezdina ND, Teplitz NA, Bergelson LD (1984)Eur J Biochem 140: 567–70.

    Google Scholar 

  9. Valentino L, Moss T, Olson E, Wang HJ, Elashoff R, Ladish S (1990)Blood 75: 1564–67.

    Google Scholar 

  10. Portoukalian J, David MJ, Shaen X, Richard M, Dubreuil C (1989)Biochem Int 18: 759–65.

    Google Scholar 

  11. Bernhard H, Meyer zum Buschenfelde KH, Dippold WG (1989)Int J Cancer 44: 155–60.

    Google Scholar 

  12. Kloppel TM, Keenan TW, Freeman MJ, Morre' DJ (1977)Proc Nat Acad Sci USA 74: 3011–13.

    Google Scholar 

  13. Portoukalian J, David MJ, Gain P, Richard M (1993)Int J Cancer 53: 948–51.

    Google Scholar 

  14. Schwartz PE, Chambers SK, Chambers JT, Gutmann J, Katopodid N, Foemmel R (1987)Cancer 60: 353–61.

    Google Scholar 

  15. Ladisch S, Gillard B (1985)Anal Biochem 146: 220–31.

    Google Scholar 

  16. Igashi H, Hirabayashi Y, Hirota M, Matsumoto M, Kato S (1987)Jpn J Cancer Res 78: 1309–13.

    Google Scholar 

  17. Horgan IE (1982)Clin Chim Acta 118: 327–31.

    Google Scholar 

  18. Ayabe M, Scishichijo S, Yokoyama MM (1989)J Clin Lab Anal 3: 301–6.

    Google Scholar 

  19. Kundu SK, Diego I, Osovitz S, Marcus DM (1985)Arch Biochem Biophys 238: 388–400.

    Google Scholar 

  20. Gornati R, Rapelli S, Montorfano G, Cattaneo C, Berra B (1991)Int J Biol Markers 6: 91–98.

    Google Scholar 

  21. Tettamanti G, Bonali F, Marchesini S, Zambotti V (1973)Biochim Biophys Acta 296: 160–70.

    Google Scholar 

  22. Sonnino S, Cantu' L, Acquotti D, Corti M, Tettamanti G (1990)Chem Phys Lipids 52: 231–41.

    Google Scholar 

  23. Sonnino S, Kirschner G, Ghidoni R, Acquotti D, Tettamanti G (1985)J Lipid Res 26: 248–57.

    Google Scholar 

  24. Sonnino S, Ghidoni R, Gazzotti G, Kirschner G, Galli G, Tettamanti G (1984)J Lipid Res 25: 620–29.

    Google Scholar 

  25. Gazzotti G, Sonnino S, Ghidoni R, Orlando P, Tettamanti G (1984)Glycoconjugate J 1: 111–21.

    Google Scholar 

  26. Chigorno V, Sonnino S, Ghidoni R, Tettamanti G (1982)Neurochem Int 5: 397–403.

    Google Scholar 

  27. Sonnino S, Acquotti D, Riboni L, Giuliani A, Kirschner G, Tettamanti G (1986)Chem Phys Lipids 42: 3–26.

    Google Scholar 

  28. Svennerholm L (1957)Biochim Biophys Acta 24: 604–11.

    Google Scholar 

  29. Miettinen J, Takki-Lukkainen JT (1959)Acta Chem Scand 13: 856–58.

    Google Scholar 

  30. Venerando B, Roberti S, Sonnino S, Fiorilli A, Tettamanti G (1982)Biochim Biophys Acta 692: 18–26.

    Google Scholar 

  31. Ladisch S, Gillard B (1987)Methods Enzymol 138: 300–6.

    Google Scholar 

  32. Sela B-A, Iliopoulos D, Guerry D, Helryn D, Coprowski H (1989)J Natl Cancer Inst 81: 1489–92.

    Google Scholar 

  33. Sonnino S, Cantu' L, Corti M, Acquotti D, Venerando B (1994)Chem Phys Lipids 71: 21–45.

    Google Scholar 

  34. Toffano G, Benvegnu' D, Bonetti AC, Leon A, Orlando P, Ghidoni R, Tettamanti G (1980)J Neurochem 35: 861–66.

    Google Scholar 

  35. Taki T, Kasama T, Handa S, Ishikawa D (1994)Anal Biochem 223: 232–38.

    Google Scholar 

  36. Marcus DM, Latov N, Hsi BP, Gillard BK (1989)J Neuroimmunol 25: 255–59.

    Google Scholar 

  37. Svennerholm L (1980)Adv Exp Biol Med 125: 11.

    Google Scholar 

  38. IUPAC-IUB Commission on Biochemical Nomenclature (1977)Lipids 12: 455–68; (1982)J Biol Chem 257: 3347–51.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Chemistry and Biochemistry, The Medical School, University of Milan, Via Saldini, 50, 20133, Milano, Italy

    Elena Negroni, Vanna Chigorno, Guido Tettamanti & Sandro Sonnino

Authors
  1. Elena Negroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vanna Chigorno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guido Tettamanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sandro Sonnino
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Abbreviations: Ganglioside nomenclature is in accordance with Svennerholm (1980) [37] and the IUPAC-IUB Recommendations (1977, 1982) [38]. GM3, II3Neu5AcLacCer, α-Neu5Ac-(2-3)-β-Gal-(1-4)-β-Glc-(1-1)-Cer; Cer, ceramide; Neu5Ac,N-acetyl-neuraminic acid;erythro-GM3, GM3 containingerythro-sphingosine;threo-GM3, GM3 containingthreo-sphingosine;erythro-C18 sphingosine, (2s,3R,4E)-2-amino-1,3-dihydroxy-octadecene;erythro-C20 sphingosine, (2S,3R,4E)-2-amino-1,3-dihydroxy-eicosene;threo-C18 sphingosine, (2S,3S,4E)-2-amino-1,3-dihydroxy-octadecene;threo-C20 sphingosine, (2S,3S,4E)-2-amino-1,3-dihydroxy-eicosene; DDQ, dichlorodicyano-benzoquinone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Negroni, E., Chigorno, V., Tettamanti, G. et al. Evaluation of the efficiency of an assay procedure for gangliosides in human serum. Glycoconjugate J 13, 347–352 (1996). https://doi.org/10.1007/BF00731466

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00731466

Keywords

Search

Navigation